| Wendy Ann Smollock, NP | |
|
600 Clements Bridge Road, Barrington, NJ 08007-1814 | |
| (856) 547-8000 | |
| (856) 547-8020 |
| Full Name | Wendy Ann Smollock |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 24 Years |
| Location | 600 Clements Bridge Road, Barrington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164453809 | NPI | - | NPPES |
| 8744905 | Medicaid | NJ | |
| 500030339 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 26NN10540600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Consonant Healing Medical Associates Of Nj Llc | 4880095637 | 18 |
| Consonant Healing Medical Associates | 1254662695 | 94 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions."
The University of Texas School of Public Health has received $20 million in funding from the United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH) today as part of an ongoing interagency partnership.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive form of lymphoma.
Researchers from King's College London have for the first time used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth.
› Verified 1 days ago
| Entity Name | Wound Healing Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225069966 PECOS PAC ID: 2264413681 Enrollment ID: O20040804000074 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions."
The University of Texas School of Public Health has received $20 million in funding from the United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH) today as part of an ongoing interagency partnership.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive form of lymphoma.
Researchers from King's College London have for the first time used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth.
› Verified 1 days ago
| Entity Name | Consonant Healing Medical Associates Of Nj Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508477399 PECOS PAC ID: 4880095637 Enrollment ID: O20210630001946 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions."
The University of Texas School of Public Health has received $20 million in funding from the United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH) today as part of an ongoing interagency partnership.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive form of lymphoma.
Researchers from King's College London have for the first time used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Ann Smollock, NP 600 Clements Bridge Road, Barrington, NJ 08007-1814 Ph: (856) 547-8000 | Wendy Ann Smollock, NP 600 Clements Bridge Road, Barrington, NJ 08007-1814 Ph: (856) 547-8000 |
News Archive
Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions."
The University of Texas School of Public Health has received $20 million in funding from the United States Food and Drug Administration (FDA) and the National Institutes of Health (NIH) today as part of an ongoing interagency partnership.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive form of lymphoma.
Researchers from King's College London have for the first time used a novel form of MRI to identify crucial developmental processes in the brain that are vulnerable to the effects of premature birth.
› Verified 1 days ago
Mrs. Beena James Joseph, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Clements Bridge Road, Barrington, NJ 08007 Phone: 856-547-8000 Fax: 856-547-8020 | |
Mr. Paul Montenegro, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Clements Bridge Road, Barrington, NJ 08007 Phone: 856-547-8000 Fax: 856-547-8020 | |
Heather Lynn Labelle, MSN, CRNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-8000 | |
Bernard William Mcandrew Iii, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-8000 Fax: 856-547-1008 | |
Beverley Hyacinth Wright, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Clements Bridge Road, Barrington, NJ 08007 Phone: 856-547-8000 Fax: 856-547-8020 | |
Chinyi Lai, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Clements Bridge Rd, Barrington, NJ 08007 Phone: 856-547-8000 Fax: 856-547-8020 |